|
CLCC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31510000001001E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.51049999969666E-08 |
| Normal-vs-Stage2 |
2.979300E-03 |
| Normal-vs-Stage3 |
7.031400E-04 |
| Normal-vs-Stage4 |
2.294200E-02 |
| Stage1-vs-Stage2 |
5.759000E-01 |
| Stage1-vs-Stage3 |
2.847200E-01 |
| Stage1-vs-Stage4 |
7.734300E-02 |
| Stage2-vs-Stage3 |
2.858000E-01 |
| Stage2-vs-Stage4 |
1.374830E-01 |
| Stage3-vs-Stage4 |
4.740400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11270000050057E-07 |
| Normal-vs-AfricanAmerican |
1.296280E-02 |
| Normal-vs-Asian |
8.681200E-03 |
| Caucasian-vs-AfricanAmerican |
5.177800E-01 |
| Caucasian-vs-Asian |
6.263400E-01 |
| AfricanAmerican-vs-Asian |
4.376600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.58049999999999E-05 |
| Normal-vs-Female |
1.55220000186418E-08 |
| Male-vs-Female |
3.480000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.629390E-01 |
| Normal-vs-Age(41-60Yrs) |
1.33390000001121E-06 |
| Normal-vs-Age(61-80Yrs) |
1.02120000000649E-06 |
| Normal-vs-Age(81-100Yrs) |
1.962980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.687600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.711200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.767400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.252000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.725600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.683000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.390180E-04 |
| Normal-vs-Grade 2 |
3.76340000274311E-08 |
| Normal-vs-Grade 3 |
5.88950000000033E-05 |
| Normal-vs-Grade 4 |
4.650300E-02 |
| Grade 1-vs-Grade 2 |
5.496400E-01 |
| Grade 1-vs-Grade 3 |
1.958190E-01 |
| Grade 1-vs-Grade 4 |
8.826500E-02 |
| Grade 2-vs-Grade 3 |
9.930400E-02 |
| Grade 2-vs-Grade 4 |
3.374400E-02 |
| Grade 3-vs-Grade 4 |
2.924200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.46189957309184E-10 |
| Normal-vs-ccB subtype |
4.989500E-04 |
| ccA subtype-vs-ccB subtype |
2.608300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.41730000002838E-06 |
| Normal-vs-N1 |
1.730560E-01 |
| N0-vs-N1 |
8.769000E-01 |
|
|
